Recombinant PAPPA 抗体 (AA 351-523)
Our Local Distributor
北京 101111
Quick Overview for Recombinant PAPPA 抗体 (AA 351-523) (ABIN7874256)
抗原
See all PAPPA 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 351-523
-
原理
- Pappalysin-1 Antibody / PAPPA
-
纯化方法
- Protein A/G affinity
-
免疫原
- A recombinant partial protein sequence (within amino acids 351-523) from the human protein was used as the immunogen for the Pappalysin-1 antibody.
-
亚型
- IgG, kappa
-
-
-
-
应用备注
- Optimal dilution of the Pappalysin-1 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.2 mg/mL
-
缓冲液
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot the Pappalysin-1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))
-
别名
- Pappalysin-1
-
背景
- Pregnancy Associated Plasma Protein (PAPP-A) is found in maternal blood that increases as pregnancy progresses, although it is not specific to pregnancy. It is principally expressed in the syncytiotrophoblast of the placenta, which forms the main source of circulating maternal PAPP-A. It cleaves insulin-like growth factor binding proteins (IGFBPs), IGFBP-4 and IGFBP-5. IGFBP-4 cleavage is enhanced significantly in the presence of bound IGF, whereas IGFBP-5 cleavage is inhibited slightly by IGF presence. It is thought to be involved in local proliferative processes such as wound healing and bone remodeling. Low plasma level of this protein has been suggested as a biochemical marker for pregnancies with aneuploid fetuses. PAPPA has also been suggested as a potential biomarker of acute myocardial infarction and Coronary Artery Disease (CAD).
-
UniProt
- Q13219
抗原
-